Literature DB >> 22206043

HCG variants, the growth factors which drive human malignancies.

Laurence A Cole1.   

Abstract

The term human chorionic gonadotropin (hCG) refers to a group of 5 molecules, each sharing the common amino acid sequence but each differing in meric structure and carbohydrate side chain structure. The 5 molecules are each produced by separate cells and each having separate biological functions. hCG and sulfated hCG are hormones produced by placental syncytiotrophoblast cells and pituitary gonadotrope cells. Hyperglycosylated hCG is an autocrine produced by placental cytotrophoblast cells. Hyperglycosylated hCG drives malignancy in placental cancers, and in testicular and ovarian germ cell malignancies. hCGβ and hyperglycosylated hCGβ are autocrines produce by most advanced malignancies. These molecules, particularly the malignancy promoters are presented in this review on hCG and cancer. hCGβ and hyperglycosylated hCGβ are critical to the growth and invasion, or malignancy of most advanced cancers. In many ways, while hCG may appear like a nothing, a hormone associated with pregnancy, it is not, and may be at the center of cancer research.

Entities:  

Keywords:  Human chorionic gonadotropin (hCG); cancer; groth factors; human malignancies; variants

Year:  2011        PMID: 22206043      PMCID: PMC3236569     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  105 in total

1.  The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua.

Authors:  E Reshef; Z M Lei; C V Rao; D D Pridham; N Chegini; J L Luborsky
Journal:  J Clin Endocrinol Metab       Date:  1990-02       Impact factor: 5.958

2.  hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation.

Authors:  Laurence A Cole
Journal:  J Reprod Immunol       Date:  2009-06-26       Impact factor: 4.054

3.  Isolation and characterization of human pituitary chorionic gonadotropin.

Authors:  S Birken; Y Maydelman; M A Gawinowicz; A Pound; Y Liu; A S Hartree
Journal:  Endocrinology       Date:  1996-04       Impact factor: 4.736

4.  The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.

Authors:  L A Cole; A Kardana; P Andrade-Gordon; M A Gawinowicz; J C Morris; E R Bergert; J O'Connor; S Birken
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

5.  Have we found the "definitive cancer biomarker"? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta expression as a key to malignancy.

Authors:  W Regelson
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

6.  Pulsatile secretion of human chorionic gonadotropin in normal adults.

Authors:  W D Odell; J Griffin
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

7.  Effect of desialylation of human chorionic gonadotropin on its metabolic clearance rate in humans.

Authors:  C Rosa; S Amr; S Birken; R Wehmann; B Nisula
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

8.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Authors:  D R Edwards; G Murphy; J J Reynolds; S E Whitham; A J Docherty; P Angel; J K Heath
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

Review 9.  Human trophoblast function during the implantation process.

Authors:  Elsebeth Staun-Ram; Eliezer Shalev
Journal:  Reprod Biol Endocrinol       Date:  2005-10-20       Impact factor: 5.211

10.  The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer.

Authors:  A M Cook; R A Huddart; G Jay; A Norman; D P Dearnaley; A Horwich
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more
  19 in total

1.  Beta-human Chorionic Gonadotropin-secreting Lung Adenocarcinoma.

Authors:  Yin Ping Wong; Geok Chin Tan; Suraya Aziz; Sucharit Pongprakyun; Fuad Ismail
Journal:  Malays J Med Sci       Date:  2015 Jul-Aug

2.  Free β-human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer.

Authors:  Adetunji T Toriola; Egle Tolockiene; Helena Schock; Helja-Marja Surcel; Anne Zeleniuch-Jacquotte; Goran Wadell; Paolo Toniolo; Eva Lundin; Kjell Grankvist; Annekatrin Lukanova
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

Review 3.  A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.

Authors:  Getachew A Woldemariam; Anthony W Butch
Journal:  Clin Chem       Date:  2014-06-04       Impact factor: 8.327

5.  Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case-control study.

Authors:  Kathrine F Vandraas; Åse V Vikanes; Nathalie C Støer; Rebecca Troisi; Olof Stephansson; Henrik T Sørensen; Siri Vangen; Per Magnus; Andrej M Grjibovski; Tom Grotmol
Journal:  BMC Cancer       Date:  2015-05-13       Impact factor: 4.430

6.  Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions.

Authors:  Sladjana Dukic-Stefanovic; Jan Walther; Sebastian Wosch; Gerolf Zimmermann; Peter Wiedemann; Henry Alexander; Thomas Claudepierre
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

7.  Human chorionic gonadotropin β induces migration and invasion via activating ERK1/2 and MMP-2 in human prostate cancer DU145 cells.

Authors:  Zongwen Li; Chunliu Li; Lianlian Du; Yan Zhou; Wei Wu
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

8.  Human chorionic gonadotropin beta subunit genes CGB1 and CGB2 are transcriptionally active in ovarian cancer.

Authors:  Marta Kubiczak; Grzegorz P Walkowiak; Ewa Nowak-Markwitz; Anna Jankowska
Journal:  Int J Mol Sci       Date:  2013-06-17       Impact factor: 5.923

Review 9.  Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.

Authors:  Siew-Fei Ngu; Karen K L Chan
Journal:  Curr Obstet Gynecol Rep       Date:  2014-01-04

10.  A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion.

Authors:  László Mangel; Krisztina Bíró; István Battyáni; Péter Göcze; Tamás Tornóczky; Endre Kálmán
Journal:  BMC Cancer       Date:  2015-12-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.